Atorvastatin Calcium Tablet
Product Images NDC 50090-5636

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-5636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)

Image-01 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 01)
Chemical structure diagram of atorvastatin calcium trihydrate, showing the molecular formula with calcium ions and three water molecules. The structure illustrates the atorvastatin molecule complexed as a calcium salt.*
FDA Label Image

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)

Image-02 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 02)
A line graph showing cumulative incidence (%) over time in years, comparing Atorvastatin and Placebo. The graph plots two curves, with Placebo showing a higher cumulative incidence than Atorvastatin. The hazard ratio (HR) is 0.64 with a 95% confidence interval (0.50-0.83) and a p-value of 0.0005, indicating statistical analysis results.*
FDA Label Image

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)

Image-03 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 03)
A line graph showing cumulative hazard percentages over time in years, comparing placebo and atorvastatin groups. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. Atorvastatin demonstrates a lower cumulative hazard than placebo, with a hazard ratio and confidence interval noted on the graph.*
FDA Label Image

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)

Image-05 (348a1a28 8e01 4e17 8df6 04d0987b2dcb 04)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for Atorvastatin 10 mg and 80 mg dosages. The x-axis shows time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) with confidence interval and p-value for statistical significance.*
FDA Label Image

Label Image (Lbl500905636)

Label Image (Lbl500905636)
Atorvastatin Calcium 10 mg oral tablets in a 30-tablet package, labeled by A-S Medication Solutions. The label includes NDC 50090-5636, storage instructions to keep at 77 degrees Fahrenheit, and dosage information stating each film-coated tablet contains atorvastatin calcium equivalent to 10 mg atorvastatin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.